Health
Health Research Advances
Hormone replacement therapies may reduce cardiovascular disease risk, according to new research. Meanwhile, Kyverna Therapeutics is making progress with a cell therapy for autoimmune diseases.
Coverage timeline — 2 articles
STAT News
Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand showing many patients remained off of other therapies a…
2026-09-24 13:52 UTC
New Scientist
Hormone replacement therapies may reduce the risk of heart attacks and stroke, but the timing of when they are started could be critical
2026-09-24 14:00 UTC